MotivationPatients with hematological malignancies are susceptible to life-threatening infections after chemotherapy. The current study aimed to evaluate whether management of such patients in dedicated inpatient and emergency wards could provide superior infection prevention and outcome.MethodsWe have developed an approach allowing to retrieve infection-related information from unstructured electronic medical records of a tertiary center. Data on 2,330 adults receiving 13,529 chemotherapy treatments for hematological malignancies were identified and assessed. Infection and mortality hazard rates were calculated with multivariate models. Patients were randomly divided into 80:20 training and validation cohorts. To develop patient-tailored r...
Objective: We aimed to determine the frequency, type, and etiology of infections and the risk factor...
Introduction: The examination of vital signs and their changes during illness can alert physicians t...
Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease ...
MotivationPatients with hematological malignancies are susceptible to life-threatening infections af...
Background and objectives: Patients admitted to the intensive care unit (ICU) have an increased risk...
IMPORTANCE: Chemotherapy-related hospitalizations in patients with advanced cancer are common, distr...
Infection hazard during the first 30 days post-chemotherapy according to: A. The underlying hematolo...
Background: The aim of this study was to develop and validate a reliable clinical prediction rule th...
Infectious complications are an important cause of morbidity and mortality in patients with hematolo...
BACKGROUND: The aim of this study was to develop and validate a reliable clinical prediction rule th...
Abstract Background Bloodstream Infections (BSIs) in neutropenic patients often cause considerable m...
Background and Objectives: Oncohematological patients have a high risk of mortality when they need t...
Nosocomial infection (NI) causes prolonged hospital stays, increased healthcare costs, and higher mo...
Nosocomial infection (NI) causes prolonged hospital stays, increased healthcare costs, and higher mo...
© 2020 by Turkish Society of Medical and Surgical Intensive Care Medicine.Objective: Hematological m...
Objective: We aimed to determine the frequency, type, and etiology of infections and the risk factor...
Introduction: The examination of vital signs and their changes during illness can alert physicians t...
Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease ...
MotivationPatients with hematological malignancies are susceptible to life-threatening infections af...
Background and objectives: Patients admitted to the intensive care unit (ICU) have an increased risk...
IMPORTANCE: Chemotherapy-related hospitalizations in patients with advanced cancer are common, distr...
Infection hazard during the first 30 days post-chemotherapy according to: A. The underlying hematolo...
Background: The aim of this study was to develop and validate a reliable clinical prediction rule th...
Infectious complications are an important cause of morbidity and mortality in patients with hematolo...
BACKGROUND: The aim of this study was to develop and validate a reliable clinical prediction rule th...
Abstract Background Bloodstream Infections (BSIs) in neutropenic patients often cause considerable m...
Background and Objectives: Oncohematological patients have a high risk of mortality when they need t...
Nosocomial infection (NI) causes prolonged hospital stays, increased healthcare costs, and higher mo...
Nosocomial infection (NI) causes prolonged hospital stays, increased healthcare costs, and higher mo...
© 2020 by Turkish Society of Medical and Surgical Intensive Care Medicine.Objective: Hematological m...
Objective: We aimed to determine the frequency, type, and etiology of infections and the risk factor...
Introduction: The examination of vital signs and their changes during illness can alert physicians t...
Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease ...